Dicot AB (XSAT:DICOT) Other Long-Term Liabilities : kr0.00 Mil (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Dicot AB Other Long-Term Liabilities?

Dicot AB's other long-term liabilities for the quarter that ended in Dec. 2023 was kr0.00 Mil.

Dicot AB Other Long-Term Liabilities Historical Data

The historical data trend for Dicot AB's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dicot AB Other Long-Term Liabilities Chart

Dicot AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Dicot AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Dicot AB Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Dicot AB Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Dicot AB's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Dicot AB (XSAT:DICOT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dicot AB (XSAT:DICOT) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

KN0:Germany

Address

Dag Hammarskjolds vag 30, Uppsala, SWE, SE 752 37

Website

http://www.dicot.se

Dicot AB is engaged in developing drugs against sexual dysfunction in Sweden. Its important products are Libiguin which is used for the treatment of erectile dysfunction and premature ejaculation in men, as well as potentially also for the treatment of decreased lust.

Dicot AB (XSAT:DICOT) Headlines

No Headlines